Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation

Many technologies in mobile health (mHealth) available for private purchase and use are becoming available in smartphone app stores worldwide. Of key concern is the proliferation of fertility-related ‘femtech’ (FRF), a category of software that is increasingly being used by women, girls and people w...

Full description

Bibliographic Details
Main Author: Catriona McMillan
Format: Article
Language:English
Published: Queensland University of Technology 2023-11-01
Series:Law, Technology and Humans
Subjects:
Online Access:https://lthj.qut.edu.au/article/view/3047
_version_ 1797509308670279680
author Catriona McMillan
author_facet Catriona McMillan
author_sort Catriona McMillan
collection DOAJ
description Many technologies in mobile health (mHealth) available for private purchase and use are becoming available in smartphone app stores worldwide. Of key concern is the proliferation of fertility-related ‘femtech’ (FRF), a category of software that is increasingly being used by women, girls and people with wombs as their main contraceptive method. Contraceptives are an important part of women’s health, and like any other medicine, they are stringently regulated in the United Kingdom (UK). ‘Digital contraceptive’ software, when marketed as such, normally falls within the definition of a ‘medical device’ and is regulated by the UK’s medical devices regime. However, some apps that may be used as digital contraceptives through tracking users’ ‘fertile windows’ sit outwith this framework and thus leave their users at risk of unplanned pregnancy. Software as a medical device (SaMD) is rapidly growing beyond the vision of the current medical devices regime, even within the past few years. This paper explores, in depth, the urgent issue of regulatory inadequacy when it comes to femtech software that may be used for contraceptive purposes. Law and regulation in this field, as they are currently constituted, are ill equipped to capture the types of mHealth and personal health tracking technologies that, normatively speaking, ought to be caught by the medical devices regime. Therefore, it is posited that while FRF poses a distinct challenge for law and regulation in that FRF may cause unwanted pregnancies, the specific issue of regulatory inadequacy posed is symptomatic of a broader problem faced by the medical devices regime.
first_indexed 2024-03-10T05:15:53Z
format Article
id doaj.art-7b47092b5b7445e8929f230f12f5fdb7
institution Directory Open Access Journal
issn 2652-4074
language English
last_indexed 2024-03-10T05:15:53Z
publishDate 2023-11-01
publisher Queensland University of Technology
record_format Article
series Law, Technology and Humans
spelling doaj.art-7b47092b5b7445e8929f230f12f5fdb72023-11-23T00:27:36ZengQueensland University of TechnologyLaw, Technology and Humans2652-40742023-11-0152789310.5204/lthj.30473370Contraception, Fertility Tracking, and the Limits of Medical Devices RegulationCatriona McMillan0https://orcid.org/0000-0003-1094-1712University of EdinburghMany technologies in mobile health (mHealth) available for private purchase and use are becoming available in smartphone app stores worldwide. Of key concern is the proliferation of fertility-related ‘femtech’ (FRF), a category of software that is increasingly being used by women, girls and people with wombs as their main contraceptive method. Contraceptives are an important part of women’s health, and like any other medicine, they are stringently regulated in the United Kingdom (UK). ‘Digital contraceptive’ software, when marketed as such, normally falls within the definition of a ‘medical device’ and is regulated by the UK’s medical devices regime. However, some apps that may be used as digital contraceptives through tracking users’ ‘fertile windows’ sit outwith this framework and thus leave their users at risk of unplanned pregnancy. Software as a medical device (SaMD) is rapidly growing beyond the vision of the current medical devices regime, even within the past few years. This paper explores, in depth, the urgent issue of regulatory inadequacy when it comes to femtech software that may be used for contraceptive purposes. Law and regulation in this field, as they are currently constituted, are ill equipped to capture the types of mHealth and personal health tracking technologies that, normatively speaking, ought to be caught by the medical devices regime. Therefore, it is posited that while FRF poses a distinct challenge for law and regulation in that FRF may cause unwanted pregnancies, the specific issue of regulatory inadequacy posed is symptomatic of a broader problem faced by the medical devices regime.https://lthj.qut.edu.au/article/view/3047femtechdigital contraceptionmedical devices regulationperiod trackers
spellingShingle Catriona McMillan
Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation
Law, Technology and Humans
femtech
digital contraception
medical devices regulation
period trackers
title Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation
title_full Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation
title_fullStr Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation
title_full_unstemmed Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation
title_short Contraception, Fertility Tracking, and the Limits of Medical Devices Regulation
title_sort contraception fertility tracking and the limits of medical devices regulation
topic femtech
digital contraception
medical devices regulation
period trackers
url https://lthj.qut.edu.au/article/view/3047
work_keys_str_mv AT catrionamcmillan contraceptionfertilitytrackingandthelimitsofmedicaldevicesregulation